Characterization of chemically induced liver injuries using gene co-expression modules

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Tawa, Gregory J ^a   AbdulHameed, Mohamed Diwan M ^a   Yu, Xueping ^a   Kumar, Kamal ^a   Ippolito, Danielle L ^b   Lewis, John A ^b   Stallings, Jonathan D ^b   Wallqvist, Anders ^a  

^a Army Medical Department Center and School   (United States)

^b US Army Center for Environmental Health Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 NAPHTHYL ISOTHIOCYANATE; 2,4 DINITROPHENOL; ALANINE AMINOTRANSFERASE; ALPHA 2 MACROGLOBULIN; ASPARTATE AMINOTRANSFERASE; CERULETIDE; DIMETHYLNITROSAMINE; ESTROGEN RECEPTOR; GLUCOCORTICOID RECEPTOR; LIPOPOLYSACCHARIDE BINDING PROTEIN; MINERALOCORTICOID RECEPTOR; N METHYLFORMAMIDE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PHOSPHODIESTERASE IV INHIBITOR; ROSIGLITAZONE; BIOLOGICAL MARKER; TRANSCRIPTOME;

A2M GENE; ALGORITHM; ANIMAL TISSUE; ARTICLE; CAR3 GENE; CHEMICALLY INDUCED LIVER INJURY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOWN REGULATION; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GOT1 GENE; GPT GENE; GULO GENE; HISTOPATHOLOGY; LBP GENE; LCN2 GENE; LIPID STORAGE; LIVER FIBROSIS; LIVER INJURY; LIVER WEIGHT; MALE; MATHEMATICAL COMPUTING; NONHUMAN; OBP3 GENE; RAT; RGN GENE; SOD2 GENE; STEATOSIS; UPREGULATION; ANIMAL; BIOLOGY; CLUSTER ANALYSIS; DRUG-INDUCED LIVER INJURY; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENETIC DATABASE; GENETICS; HUMAN; METABOLISM; PROCEDURES; REPRODUCIBILITY; SIGNAL TRANSDUCTION;

RATTUS;

ALGORITHMS; ANIMALS; BIOLOGICAL MARKERS; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; DRUG-INDUCED LIVER INJURY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; HUMANS; RATS; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION; TRANSCRIPTOME;

EID: 84907190398     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0107230     Document Type: Article

References (58)

1. Deeter DP, Gaydos, Joel C (1993) Textbook of Military Medicine - Part III, Disease and the Environment. Washington, DC: Office of the Surgeon General, Department of the Army, United States of America. 617 p.
2. Rossi E, Adams LA, Bulsara M, Jeffrey GP (2007) Assessing liver fibrosis with serum marker models. Clin Biochem Rev 28: 3-10.
3. Parkes J, Guha IN, Harris S, Rosenberg WM, Roderick PJ (2012) Systematic review of the diagnostic performance of serum markers of liver fibrosis in alcoholic liver disease. Comp Hepatol 11: 5.
4. Blomme EA, Yang Y, Waring JF (2009) Use of toxicogenomics to understand mechanisms of drug-induced hepatotoxicity during drug discovery and development. Toxicol Lett 186: 22-31.
5. Gant TW, Zhang SD, Taylor EL (2009) Novel genomic methods for drug discovery and mechanism-based toxicological assessment. Curr Opin Drug Discov Devel 12: 72-80.
6. Gresham V, McLeod HL (2009) Genomics: applications in mechanism elucidation. Adv Drug Deliv Rev 61: 369-374.
7. Panagiotou G, Taboureau O (2012) The impact of network biology in pharmacology and toxicology. SAR QSAR Environ Res 23: 221-235.
8. Smalley JL, Gant TW, Zhang SD (2010) Application of connectivity mapping in predictive toxicology based on gene-expression similarity. Toxicology 268: 143-146.
9. Bai JP, Abernethy DR (2013) Systems pharmacology to predict drug toxicity: integration across levels of biological organization. Annu Rev Pharmacol Toxicol 53: 451-473.
10. Ganter B, Snyder RD, Halbert DN, Lee MD (2006) Toxicogenomics in drug discovery and development: mechanistic analysis of compound/class-dependent effects using the DrugMatrix database. Pharmacogenomics 7: 1025-1044.
11. Segal E, Friedman N, Koller D, Regev A (2004) A module map showing conditional activity of expression modules in cancer. Nat Genet 36: 1090-1098.
12. Iskar M, Zeller G, Blattmann P, Campillos M, Kuhn M, et al. (2013) Characterization of drug-induced transcriptional modules: towards drug repositioning and functional understanding. Mol Syst Biol 9: 662.
13. Rinaldo A, Bacanu SA, Devlin B, Sonpar V, Wasserman L, et al. (2005) Characterization of multilocus linkage disequilibrium. Genet Epidemiol 28: 193-206.
14. Ihmels J, Friedlander G, Bergmann S, Sarig O, Ziv Y, et al. (2002) Revealing modular organization in the yeast transcriptional network. Nat Genet 31: 370-377.
15. Bergmann S, Ihmels J, Barkai N (2003) Iterative signature algorithm for the analysis of large-scale gene expression data. Phys Rev E Stat Nonlin Soft Matter Phys 67: 031902.
16. Feala JD, Abdulhameed MD, Yu C, Dutta B, Yu X, et al. (2013) Systems biology approaches for discovering biomarkers for traumatic brain injury. J Neurotrauma 30: 1101-1116.
17. Judson R, Elloumi F, Setzer RW, Li Z, Shah I (2008) A comparison of machine learning algorithms for chemical toxicity classification using a simulated multiscale data model. BMC Bioinformatics 9: 241.
18. Natsoulis G, El Ghaoui L, Lanckriet GR, Tolley AM, Leroy F, et al. (2005) Classification of a large microarray data set: algorithm comparison and analysis of drug signatures. Genome Res 15: 724-736.
19. Boone L, Meyer D, Cusick P, Ennulat D, Bolliger AP, et al. (2005) Selection and interpretation of clinical pathology indicators of hepatic injury in preclinical studies. Vet Clin Pathol 34: 182-188.
20. Davis AP, Murphy CG, Johnson R, Lay JM, Lennon-Hopkins K, et al. (2013) The Comparative Toxicogenomics Database: update 2013. Nucleic Acids Res 41: D1104-1114.
21. Ganter B, Tugendreich S, Pearson CI, Ayanoglu E, Baumhueter S, et al. (2005) Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action. J Biotechnol 119: 219-244.
22. Natsoulis G, Pearson CI, Gollub J, Eynon PB, Ferng J, et al. (2008) The liver pharmacological and xenobiotic gene response repertoire. Mol Syst Biol 4: 175.
23. Carlson MC (2002) rat2302.db: Affymetrix Rat Genome 230 2.0 Array Annotation Data (Chip rat2302), R package version 2.8.1. Santa Clara (California): Affymetrix.
24. Kauffmann A, Gentleman R, Huber W (2009) arrayQualityMetrics - a bioconductor package for quality assessment of microarray data. Bioinformatics 25: 415-416.
25. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
26. Gentleman R, Carey V, Huber W, Hahne F (2013) genefilter: Methods for Filtering Genes from Microarray Experiments, R package version 1.40.0. Seattle (Washington): Bioconductor.
27. Bourgon R, Gentleman R, Huber W (2010) Independent filtering increases detection power for high-throughput experiments. Proc Natl Acad Sci U S A 107: 9546-9551.
28. Langfelder P, Zhang B, Horvath S (2008) Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R. Bioinformatics 24: 719-720.
29. Yu X, Wallqvist A, Reifman J (2012) Inferring high-confidence human protein-protein interactions. BMC Bioinformatics 13: 79.
30. Csardi G, Kutalik Z, Bergmann S (2010) Modular Analysis of Gene Expression Data with R. Bioinformatics. 26: 1376-1377.
31. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M (2012) KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res 40: D109-114.
32. Uehara T, Ono A, Maruyama T, Kato I, Yamada H, et al. (2010) The Japanese toxicogenomics project: application of toxicogenomics. Mol Nutr Food Res 54: 218-227.
33. Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, et al. (2013) NCBI GEO: archive for functional genomics data sets - update. Nucleic Acids Res 41: D991-995.
34. Moreno M, Chaves JF, Sancho-Bru P, Ramalho F, Ramalho LN, et al. (2010) Ghrelin attenuates hepatocellular injury and liver fibrogenesis in rodents and influences fibrosis progression in humans. Hepatology 51: 974-985.
35. Spicker JS, Brunak S, Frederiksen KS, Toft H (2008) Integration of clinical chemistry, expression, and metabolite data leads to better toxicological class separation. Toxicol Sci 102: 444-454.
36. Peraza MA, Burdick AD, Marin HE, Gonzalez FJ, Peters JM (2006) The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR). Toxicol Sci 90: 269-295.
37. Sarnes E, Crofford L, Watson M, Dennis G, Kan H, et al. (2011) Incidence and US costs of corticosteroid-associated adverse events: a systematic literature review. Clin Ther 33: 1413-1432.
38. Mauvais-Jarvis F, Clegg DJ, Hevener AL (2013) The role of estrogens in control of energy balance and glucose homeostasis. Endocr Rev 34: 309-338.
39. Larson JL, Pino MV, Geiger LE, Simeone CR (1996) The toxicity of repeated exposures to rolipram, a type IV phosphodiesterase inhibitor, in rats. Pharmacol Toxicol 78: 44-49.
40. Teixeira MM, Gristwood RW, Cooper N, Hellewell PG (1997) Phosphodiesterase (PDE)4 inhibitors: anti-inflammatory drugs of the future? Trends Pharmacol Sci 18: 164-171.
41. Beghe B, Rabe KF, Fabbri LM (2013) Phosphodiesterase-4 inhibitor therapy for lung diseases. Am J Respir Crit Care Med 188: 271-278.
42. Buttgereit F, Saag KG, Cutolo M, da Silva JA, Bijlsma JW (2005) The molecular basis for the effectiveness, toxicity, and resistance to glucocorticoids: focus on the treatment of rheumatoid arthritis. Scand J Rheumatol 34: 14-21.
43. Seki K, Minami Y, Nishikawa M, Kawata S, Miyoshi S, et al. (1983) "Nonalcoholic steatohepatitis" induced by massive doses of synthetic estrogen. Gastroenterol Jpn 18: 197-203.
44. Koricanac G, Tepavcevic S, Romic S, Zivkovic M, Stojiljkovic M, et al. (2012) Estradiol enhances effects of fructose rich diet on cardiac fatty acid transporter CD36 and triglycerides accumulation. Eur J Pharmacol 694: 127-134.
45. Nakazato K, Takada H, Iha M, Nagamine T (2010) Attenuation of N-nitrosodiethylamine-induced liver fibrosis by high-molecular-weight fucoidan derived from Cladosiphon okamuranus. J Gastroenterol Hepatol 25: 1692-1701.
46. Zhang L, Ye Y, An Y, Tian Y, Wang Y, et al. (2011) Systems responses of rats to aflatoxin B1 exposure revealed with metabonomic changes in multiple biological matrices. J Proteome Res 10: 614-623.
47. Thatishetty AV, Agresti N, O'Brien CB (2013) Chemotherapy-induced hepatotoxicity. Clin Liver Dis 17: 671-686, ix-x.
48. Hitchcock AL, Krebber H, Frietze S, Lin A, Latterich M, et al. (2001) The conserved npl4 protein complex mediates proteasome-dependent membrane-bound transcription factor activation. Mol Biol Cell 12: 3226-3241.
49. Jump DB, Botolin D, Wang Y, Xu J, Christian B, et al. (2005) Fatty acid regulation of hepatic gene transcription. J Nutr 135: 2503-2506.
50. Robertson DG, Loewen G, Walsh KM, Dethloff LA, Sigler RS, et al. (1993) Subacute and subchronic toxicology studies of CI-986, a novel anti-inflammatory compound. Fundam Appl Toxicol 20: 446-455.
51. Grimbert S, Pessayre D, Degott C, Benhamou JP (1994) Acute hepatitis induced by HMG-CoA reductase inhibitor, lovastatin. Dig Dis Sci 39: 2032-2033.
52. Gressier L, Pruvost-Balland C, Dubertret L, Viguier M (2009) [Atorvastatin-induced drug reaction with eosinophilia and systemic symptoms (DRESS)]. Ann Dermatol Venereol 136: 50-53.
53. Bataller R, Brenner DA (2005) Liver fibrosis. J Clin Invest 115: 209-218.
54. Ozer J, Ratner M, Shaw M, Bailey W, Schomaker S (2008) The current state of serum biomarkers of hepatotoxicity. Toxicology 245: 194-205.
55. Rossi E, Adams L, Prins A, Bulsara M, de Boer B, et al. (2003) Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients. Clin Chem 49: 450-454.
56. Laulederkind SJ, Hayman GT, Wang SJ, Smith JR, Lowry TF, et al. (2013) The Rat Genome Database 2013 - data, tools and users. Brief Bioinform 14: 520-526.
57. Chen Y, Zhang Y, Yin Y, Gao G, Li S, et al. (2005) SPD - a web-based secreted protein database. Nucleic Acids Res 33: D169-173.
58. Yang X (2012) Current and emerging biomarkers of hepatotoxicity. Current Biomarker Findings 2: 12.